Sanjeev Vernekar

Center for Drug Design University of Minnesota, Twin Cities, Minneapolis, MN 
"Sanjeev Vernekar"
Mean distance: 9.88
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sahani RL, Diana-Rivero R, Vernekar SKV, et al. (2021) Design, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74. Viruses. 13
Wang L, Casey MC, Vernekar SKV, et al. (2021) Novel PF74-like small molecules targeting the HIV-1 capsid protein: Balance of potency and metabolic stability. Acta Pharmaceutica Sinica. B. 11: 810-822
Wang L, Casey MC, Vernekar SKV, et al. (2020) Novel HIV-1 capsid-targeting small molecules of the PF74 binding site. European Journal of Medicinal Chemistry. 204: 112626
Wang L, Casey MC, Vernekar SKV, et al. (2020) Chemical profiling of HIV-1 capsid-targeting antiviral PF74. European Journal of Medicinal Chemistry. 200: 112427
Vernekar SKV, Sahani RL, Casey MC, et al. (2020) Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules. Viruses. 12
Vernekar SKV, Tang J, Wu B, et al. (2017) Double-winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity. Journal of Medicinal Chemistry
Tang J, Vernekar SK, Chen YL, et al. (2017) Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase. European Journal of Medicinal Chemistry. 133: 85-96
See more...